Downloads: 2
Original Article | Ayurveda | Volume 15 Issue 4, April 2026 | Pages: 463 - 469 | India
Study the Efficacy of Erand Taila and Triphala Kwath in Vatarakta
Abstract: Background: Vatarakta is a widespread metabolic disorder characterized by an imbalance of both Vata Dosha and Rakta Dhatu. Clinically, it closely correlates with Gouty Arthritis. The condition manifests as Sandhi Shoola, Sandhi Sotha, Sandhi Stabdhata, Daha, Toda, Twak Vaivarnyata, and Kandu. The modern therapy depends on NSAIDs and uricosuric medications, both of which only provide symptomatic relief. Ayurveda recommends Sneha Yukta Virechana by using the drugs Erand Taila and Triphala Kwath. These drugs promote Deepana and Pachana of Ama Dosha as well as Vatanulomana, Pitta Nisarana, and Rakta Vishodhana by removing the Avarana developed by the Doshas. Methods: Forty patients who met the criteria were selected from the OPD of GACH, Patna, fulfilling the criteria, and almost all the patients completed the trial. The trial drug ?Erand Taila and Triphala Kwath? was given to the patients orally for 30 days, and three planned follow-ups were conducted to assess the clinical status: the first on day seven, the second on day fifteen, and the final evaluation on day thirty. Conclusion: A total of 95% of patients were noted to have improved signs and symptoms. In contrast, the remaining individuals with a chronic history of the disease showed no improvement.
Keywords: Vatarakta management, Ayurvedic detox therapy, Erand Taila, Triphala Kwath, Gouty arthritis relief
How to Cite?: Lipsa Acharya, Vijay Shankar Pandey, "Study the Efficacy of Erand Taila and Triphala Kwath in Vatarakta", Volume 15 Issue 4, April 2026, International Journal of Science and Research (IJSR), Pages: 463-469, https://www.ijsr.net/getabstract.php?paperid=SR26406113931, DOI: https://dx.dx.doi.org/10.21275/SR26406113931